Aurora Analytica welcomes Håkon Thomas Olsen to its Advisory Board. With deep expertise in commercial strategy, business development, and financial leadership, Håkon will help drive the company’s growth and shape the future of AI-powered clinical trial optimization.

Many platforms give you access to valuable datasets — but leave you figuring out how to combine them into something useful. Aurora Analytica™ takes a different approach. With the Aurora Suite™, users define how data connects, creating dynamic insights that drive trial strategy. It’s the difference between having ingredients on the shelf and having a kitchen to prepare the meal.

Clinical trial teams are often stuck navigating with “hundreds of paper maps”—disconnected spreadsheets, siloed platforms, and fragmented insights. Traditional data tools only provide pieces of the puzzle. Aurora Analytica™’s Decision Engines™ transform this experience by combining datasets, generating new insights, and automating workflows—all within the Aurora Suite™. Instead of juggling tools, teams gain a complete, dynamic map of their trial, enabling faster, smarter, and more confident decisions across the full lifecycle.

Recently, we had the opportunity to present our vision to the European Innovation Council (EIC) as part of a detailed and comprehensive evaluation process. Their response reinforced the strength of our approach and the transformational potential of the Aurora Suite.

We are thrilled to announce that Aurora Analytica has been awarded the prestigious Start-up 2 (Oppstart 2) grant from Innovation Norway.

By leveraging our expertise and proprietary decision engines, we provided a comprehensive assessment of trial feasibility, competitive landscape, and site intelligence, helping our client reduce uncertainty and optimize trial planning. The results?

In this article, Bhavish Lekh (CEO) drawsfrom over 10 years of experience in feasibility and predictive analytics at top companies such as IQVIA, Medpace, Synteract, and Syneos Health. Bhavish explores key obstacles for Pharma, Biotech, and CROs, including the high costs of clinical trials, particularly the hidden costs associated with trial setup.

At Aurora Analytica, we are driven by a clear mission: to transform clinical research through the power of analytics, data, and AI—accelerating trials, improving quality, and ultimately getting treatments to patients faster.

Our advanced AI model built to transform clinical trials with automation, streamlined design, data-driven recommendations, and insights across millions of data points.

We are thrilled to announce the release of our Aurora Suite™ Teaser Video! This exciting video provides a sneak peek into the revolutionary capabilities of our suite of tools designed to transform the clinical trial landscape.

Our article delves into the most pressing issues facing the pharmaceutical industry today, specifically around optimizing clinical trials. Backed by real-world perspectives gathered from our Aurora Analytica Insights Survey, we discuss views of industry stakeholders across Biotech, Pharma, and CROs.

We are thrilled to announce that Aurora Analytica has been awarded a prestigious grant from Innovation Norway.

At the heart of Aurora Consulting's mission is a profound dedication to your project's triumph. Our foundation is built on understanding and addressing the pivotal questions that shape the landscape of healthcare innovation.